Bacteria-resistant catheters to reduce infection
16 March, 2015Flinders University researchers are undertaking a project to reduce urinary tract infections associated with the use of catheters during hospital stays.
Prototype medical device to improve spinal surgery
10 March, 2015Flinders University researchers are developing a surgical instrument that will enable bone graft delivery during minimally invasive spinal fusion procedures.
Enrolment hold for GI Dynamics ENDO Trial
06 March, 2015Shares in medical device company GI Dynamics (ASX:GID) dropped by over 50% after the US FDA placed an enrolment hold on one of its clinical trials, following four cases of infection among participants.
Novotech awarded CRO Best Practice Award
27 February, 2015Sydney-based contract research organisation (CRO) Novotech has been awarded the CRO Best Practice Award for the third time in recent years by Frost & Sullivan.
Australian Innovation System Report released
26 February, 2015Innovation is key for Australian businesses to remain competitive according to the latest Australian Innovation System Report, which has been released by the office of the Chief Economist and the Department of Industry and Science.
Phosphagenics to sell bioElixia business
25 February, 2015 by Dylan Bushell-EmblingPhosphagenics (ASX:POH) has put its bioElixia range of cosmetic products up for sale as part of plans to focus on its core drug delivery business.
Phylogica lines up EU patent for Phylomer screening
25 February, 2015 by Dylan Bushell-EmblingPhylogica (ASX:PYC) has been issued a notice of allowance for an EU patent covering using its Phylomer peptide libraries for drug discovery screening.
AusBiotech comments on draft IP Toolkit for research collaboration
24 February, 2015AusBiotech has made a submission to IP Australia on the draft IP Toolkit for research collaborations between research institutes and companies, where it said the draft IP Toolkit could offer useful guidance to SMEs who wish to engage in collaborations.
Anatara Lifesciences names new CEO
24 February, 2015 by Dylan Bushell-EmblingAnatara Lifesciences (ASX:ANR) has made three new executive appointments including a new CEO and has reported a 530% increase in its net loss for the first half of FY15.
Saluda raises $10m for neuromodulation device
23 February, 2015 by Dylan Bushell-EmblingNICTA spinoff Saluda Medical has raised $10m in Series B funding to help develop Evoke, its neuromodulation device for treating chronic pain and other conditions.
Replacing leaky heart valves in situ
23 February, 2015Surgeons in Sydney have successfully replaced leaky mitral valves in two human hearts while they were still beating.
Annual survey of Australia's biotech industry closing soon
19 February, 2015The annual AusBiotech CEO Industry Position Survey is in its final weeks of data collection and biotech industry leaders (CEOs, MDs) are urged to assist industry development with experiences, knowledge, key metrics and political insight.
Anatara's Detach reduces piglet mortality in farm trial
18 February, 2015 by Dylan Bushell-EmblingAnatara Lifesciences (ASX:ANR) said its Detach product was able to reduce piglet mortality compared with a placebo during an on-site trial at a Victorian farm.
Call for transitional arrangements for R&D Tax incentive cap
17 February, 2015The passage of legislation last week to cap claims on the Research and Development (R&D) Tax Incentive and its retrospective application to 1 July 2014 has prompted calls for the government to provide transitional arrangements for biotech companies abandoned in a difficult position.
Starpharma 1H losses grow on trial spending
17 February, 2015 by Dylan Bushell-EmblingStarpharma (ASX:SPL) reported a wider net loss for the first half of FY15 on increased clinical trial spending, but a capital raising left the company in an improved cash position.
